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INTRODUCTION
Hydrogen sulfide (H2S), recognized as a 
new gaseous mediator, plays numerous 
roles both in normal physiological and 
pathophysiological conditions). 
Three enzymes endogenously synthe-
size H2S: cystathionine-ß-synthase (CBS), 
cystathionine-γ-lyase (or cystathionase, 
CSE) and 3-mercapto-sulphurtransferase 
(2, 3). H2S plays numerous roles both in 
normal physiological and pathophysiologi-
cal conditions (1). As nitric oxide (NO), 
H2S is involved in the regulation of vascu-
lar tone. Experimental evidence has shown 
that H2S evokes concentration-dependent 
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ABSTRACT
Introduction: Insufficient mesenteric perfusion is a dramatic complication in critically ill patients. Hydrogen 
sulfide, a newly recognized endogenous gaseous mediator, acts as an intestinal vasoactive agent and seems to 
protect against mesenteric ischemic damage. We investigated whether sodium hydrogen sulfide, a hydrogen 
sulfide donor, can improve mesenteric perfusion in an experimental model of pigs, both in physiological and 
ischemic conditions.
Methods: The study was conducted at Careggi University Hospital (Florence, IT). Fourteen male domestic 
pigs (≈10 kg) were anesthetized and mechanically ventilated. Animals were randomized in control and isch-
emia groups. Mesenteric ischemia was induced with a positive end-expiratory pressure of 15 cmH2O. After 
mini-laparotomy, each animal received incremental doses of sodium hydrogen sulfide every 20 minutes. Per-
fusion of both the jejunal mucosa and sternal skin were measured by laser Doppler flowmeter, and systemic 
hemodynamic parameters were monitored. 
Results: In the control group, sodium hydrogen sulfide was able to significantly improve the mesenteric per-
fusion, showing a 50% increase from the baseline blood flow. In the ischemia group, NaHS-induced a twofold
increase of the mesenteric post-ischemic perfusion with a recovery up to 70% of pre- positive end-expiratory 
pressure mesenteric blood flow. Sodium hydrogen sulfide did not directly or indirectly (by blood flow redistri-
bution) affect the sternal skin microcirculation, heart rates, or mean arterial pressure, suggesting a tissue-spe-
cific micro-vascular action.
Conclusions: In a porcine model, we observed a mesenteric perfusion recovery mediated by administration of 
hydrogen sulfide donor without affecting general hemodynamic.
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relaxation of many vascular districts, such 
as the aorta, through ATP-sensitive potas-
sium (K+ATP)-channels opening (4), the 
portal vein (5), and the mesenteric artery 
bed (6). In particular, according to the Au-
thors, the sensitivity of mesenteric artery 
bed to H2S was about fivefold higher than 
in the aorta in rats. The supposed H2S-se-
lectivity for the mesenteric vascular sys-
tem has recently been confirmed. Yang et 
al. demonstrated that CSE knock-out mice 
displayed hypertension and diminished en-
dothelium-dependent vascular relaxation, 
which were more pronounced in the mes-
enteric district (7).
Decreased mesenteric perfusion is a severe 
complication occurring in critically ill pa-
tients (8, 9). The mesenteric hypoperfu-
sion can be linked to an increase in intra-
abdominal pressure (e.g. traumatic injury, 
retroperitoneal hematoma) or shock. The 
switch from aerobic to anaerobic metabo-
lism in the mesenteric bed promotes the 
secretion of multiple vasoactive substances 
(e.g. nitric oxide) to improve tissue perfu-
sion through local vasodilation. Eventually, 
persistent vasodilation may adversely affect 
both macro- and microcirculation, leading 
to tissue hypoperfusion (10). In mechani-
cally ventilated patients affected by acute 
respiratory distress syndrome, high respi-
ratory pressures, including positive end-ex-
piratory pressure (PEEP), may exacerbate 
mesenteric hypoperfusion (10). High PEEP 
may lead to both regional and systemic ad-
verse effects due to increased intra-thoracic 
pressures and decreased venous return to 
right atrium (11). The consequent reduc-
tion in cardiac output redistributes blood 
flow away from the splanchnic circulation 
with an elevated risk for mesenteric isch-
emia, as already confirmed in rodents and 
pigs (11). 
The aim of the present study was to exam-
ine the effect of incremental intravenous 
doses of sodium hydrogen sulfide (NaHS), 
a H2S donor, within a physiological range 
on pig mesenteric microcirculatory blood 
flow in both physiological and PEEP-in-
duced ischemic conditions.
METHODS
Animals and compounds. Fourteen male 
pigs, weight 10 Kg±1 (SEM), were used 
with the approval of the Local Animal Ex-
periment Ethics Committee. All procedures 
were carried out according to the guide-
lines of the National Institute of Health for 
the care and use of laboratory animals.
As a source of H2S in sodium-chloride solu-
tion (0.9%, vehicle), we used sodium hy-
drogen sulfide (NaHS, Sigma-Aldrich Srl, 
Milano, Italy), which reacts with water (1 
ml/kg), producing H2S (5).
Anesthesia. After overnight fast, pigs were 
anesthetized with ketamine (10 mg/Kg 
i.m.) and maintained under anesthesia 
with nitrous oxide (N2O) and sevoflurane 
(Sevorane®, Baxter) at 1.0 MAC. Neuro-
muscular block was achieved with a bo-
lus of vecuronium bromide (0.1 mg/kg) 
and maintained with additional boluses of 
0.015 mg/kg every 30 min. Animals were 
intubated in a supine position with a 4.5-
5.0 mm inner diameter cuffed endotracheal 
tube and mechanically ventilated with tidal 
volume of 8 ml/kg and FiO2 set at 50%. 
The following physiological parameters 
were monitored:
1) electrocardiogram (lead DII);
2) inspired and expired oxygen and carbon 
dioxide concentrations (%);
3) SpO2 (ear lobe);
4) invasive femoral arterial pressure (20 G).
Surgical preparation. A mini-laparotomy 
was performed to expose the Treitz muscle. 
The Treitz muscle was sectioned to access 
the jejunum. In order to evaluate the mes-
enteric perfusion, a laser Doppler flowme-
ter probe was positioned in the first jejunal 
Effects of H2S-donor on pig mesenteric perfusion
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loop (12). For better evaluation, the probe 
was placed near a micro-vessel on the same 
course of mesenteric artery root and kept 
in place with a 3/0 Dexon suture. A sec-
ond Doppler flowmeter probe was placed 
on the sternal skin to measure cutaneous 
perfusion. At the end of each experimental 
surgery, the mini-laparotomy was sutured 
and the animal was sacrificed with an in-
travenous bolus of KCl.
Experimental protocol. The study proto-
col is summarized in Figure 1. Panel A 
and Panel B illustrate respectively the ex-
perimental protocol for both control and 
ischemia-induced groups. In the ischemia 
groups, a PEEP of 15 cmH2O was applied 
to achieve mesenteric hypo-perfusion, as 
according to many other similar study pro-
tocols (13, 14). The administration of the 
drug was shifted 40 minutes later than the 
control group in order to achieve hemody-
namic stabilization. 
An intravenous bolus of NaHS (10 ml) 
was administrated at a constant rate of 60 
seconds every 20 minutes in the follow-
ing order: 1 µM/kg, 3 µM/kg, 10 µM/kg, 
30 µM/kg, 100 µM/kg, 300 µM/kg, 1000 
µM/kg. No artifact signal due to the injec-
tion procedure has been noticed. In both 
groups, the baseline measurements were 
performed twenty minutes after the induc-
tion of anesthesia (stabilization period), 
and subsequently repeated 10 minutes 
after each NaHS administration. In both 
groups, mesenteric perfusion was recorded 
from the end of the stabilization period un-
til the death of the animal (Figure 1 panel 
A and B). 
Laser Doppler Flow Measurements. In order 
to measure the tissue perfusion, a Laser 
Doppler Flowmeter (Periflux System 5000, 
Perimed, Milan, Italy) was used, with a 
small straight probe (probe 407-1) on the 
sternal skin and a needle probe (probe 
Figure 1 -  Study protocol. Each point time represent the timing of data collection.
Panel A: control animals; Panel B: ischemia-induced animals. PEEP ventilation has been fixed at 15 cm
H2O and 40 minutes have been waited for the stabilization of hemodynamic parameters of the animal.
PEEP = positive end-expiratory pressure.
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411) in the jejunal mucosa (see above). 
Basal blood flow was defined as the mean 
of blood flow (expressed as Perfusion Unit, 
PU) within a 10-minute interval immedi-
ately after the stabilization period. The re-
sponse to each NaHS dose was expressed as 
the mean of blood flow (expressed as Perfu-
sion Unit, PU). Changes in blood flow were 
expressed as percentage increases relative 
to the basal level. For the ischemia group, 
we considered as basal level the mean blood 
flow within a 10 minutes interval after the 
PEEP stabilization period.
Statistics. GraphPad Prism 5 (GraphPad 
Software Inc., San Diego, CA) was used 
for statistical analysis. All results were ex-
pressed as mean±standard error of mean 
(SEM). Statistical analysis was made by t-
test or one-way analysis of variance (ANO-
VA) for repeated measures followed by 
Bonferroni post hoc test. P value was con-
sidered significant if greater than 0.05.
Figure 2 - Effect of serial in-
travenous bolus of NaHS on 
mean arterial pressure in con-
trol (Panel A) and ischemia 
groups (Panel B). Data are 
expressed as mean ± SEM. 
Statistical analysis: ANOVA; 
*p<0.05.
NaHS = sodium hydrogen 
sulfide; SEM = standard er-
ror of mean; ANOVA = anal-
ysis of variance.
Effects of H2S-donor on pig mesenteric perfusion
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RESULTS
Effect of NaHS on hemodynamic parameters. 
In the control group, the serial intravenous 
doses of NaHS did not significantly modify 
the mean arterial pressure(MAP) (Figure 
2, panel A), and the HR. In the ischemia-
induced group, the increase in intra-tho-
racic pressures caused a significant reduc-
tion in MAP (Figure 2, panel B) associated 
with not-significant changes in HR. After 
incremental bolus of NaHS, MAP values 
progressively increased, recovering values 
comparable with the pre-ischemic mea-
sures after the 3 µg/kg bolus (p=0.03; Fig-
ure 2, panel B). Gas exchange (pO2, pCO2) 
and metabolic status (pH, lactate) did not 
change significantly during H2S infusion in 
both groups. In particular, mean (±SEM) 
PaCO2 was 38.6±1.1 mmHg in control 
group and 37.9±0.9 in the experimental 
group. Effect of NaHS on perfusion of jeju-
Figure 3 - Panel A: Baseline mesenteric and cutaneous blood flow (expressed in Perfusion Units) in 
both control and PEEP-induced ischemia groups; Panel B: Effect of serial intravenous doses of NaHS on 
jejunal mucosa perfusion and sternal skin in control group. Doses were administrated each 20 minutes.
Changes in blood flow are expressed in percentage of the basal level; Panel C: Effect of PEEP (15 cm-
H2O) on pig mesenteric and cutaneous blood flow (expressed as perfusion units, PU); Panel D: Effect 
of serial intravenous doses of NaHS on jejunal mucosa perfusion and sternal skin in ischemia-induced 
group. Doses were administrated each 20 minutes. Changes in blood flow are expressed in percentage 
of the basal level; Data are expressed as mean ± SEM. Statistical analysis: t-test (panel A); ANOVA 
(panels B, C and D); *p<0.05.
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nal mucosa and sternal skin. The baseline 
flow did not differ between the two studied 
groups, neither in the mesenteric nor cu-
taneous districts (248 vs. 229 PU, p=0.8; 
35.7 vs. 36.3 PU, p=0.8, respectively; Fig-
ure 3, panel A). In the control group, jejunal 
mucosa perfusion increased with a peak at 
10 µM/Kg (Figure 3, panel B). Conversely, 
a not-significant effect was observed on 
the sternal skin, suggesting that NaHS 
did not affect the cutaneous microcircula-
tion (Figure 3, panel B) (p<0.05). In the 
PEEP-induced ischemia group, the jejunal 
mucosa perfusion significantly decreased 
66% from the baseline immediately after 
application of the PEEP (p=0.009, Figure 
3, panel C), whereas skin perfusion was not 
significantly affected, suggesting that PEEP 
application selectively impaired the mes-
enteric perfusion (Figure 3, panel C). As 
observed in the control group, in the isch-
emia group the administration of NaHS 
significantly increased perfusion of jejunal 
mucosa, with a recovery of 70% of pre-
ischemic mesenteric flow (Figure 3, panel 
D) (p<0.05). Finally, ischemic animals 
showed higher increases in jejunal muco-
sa blood flow than animals in the control 
group (p=0.02, Figure 3).
DISCUSSION
Our study shows that NaHS, an H2S donor, 
can restore PEEP-mediated splanchnic hy-
poperfusion to 70% of pre-PEEP values. 
These results are important if considering 
that with the aim to improve splanchnic 
perfusion, the most widely utilized drugs 
are dopamine receptor agonists (dopamine 
or fenoldopam), since they are supposedly 
free from side effects (15, 16) but without 
definitive evidence of their beneficial role 
in intestinal mucosa perfusion (17).
We also observed that, in the control group, 
low concentrations of H2S were able to in-
crease the intestinal mucosal perfusion 
up to 50% of the baseline blood flow. The 
H2S-induced vasodilatation appeared to be 
limited to the mesenteric micro-vascular 
district for two reasons:
1) it did not result in any clinically signifi-
cant systemic hemodynamic effect;
2) it did not directly affect the cutaneous 
microcirculation, suggesting a tissue-
selectivity.
Although H2S is known to have negative 
inotropic and chronotropic effects, the 
absence of a significant systemic hemo-
dynamic change in our experiments can 
be explained by the acute administration 
of the compound, whereas the absence of 
metabolic modifications is in line with pre-
vious findings on the porcine ischemia/re-
perfusion model (18).
The H2S-induced improvement in mesen-
teric microcirculation perfusion was con-
firmed in PEEP-ischemic animals. PEEP 
produced a mesenteric hypo-perfusion, 
cutting down 66% of the mesenteric blood 
flow, consistent with previous studies (13, 
14). In this condition, the H2S-induced vas-
cular relaxation was associated with a 70% 
restoration of the pre-ischemic mesenteric 
blood flow at NaHS dose of 1000 µg/kg 
(Figure 3, panel C). As could be expected, 
in the ischemic group, the mesenteric mu-
cosa seemed to be more H2S-responsive 
than in the control group, especially at el-
evated doses (Figure 3, panel B and D). Skin 
perfusion did not significantly change, sug-
gesting that the effects of H2S were exerted 
mostly in the central blood compartment 
rather than in the peripheral circulation 
(Figure 3, panel D). Our findings confirmed 
the property of exogenous H2S in the mes-
enteric circulation of pigs, which was pre-
viously shown in small animal models (7). 
As shown in Figure 3 (panels D), there is 
a dip in the dose/effect curve. This seems 
to be far from a pure sigmoidal dose/effect 
curve, and is probably caused by the limited 
sample. Limitations of this study must be 
Effects of H2S-donor on pig mesenteric perfusion
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mentioned. Although our study provided 
proof of the concept of H2S-related marked 
improvement of mesenteric perfusion, it 
does not allow quantitative conclusions to 
be drawn about the effective increases in 
blood fl ow, not having an untreated isch-
emia group. Also, the decrease in splanch-
nic perfusion induced by PEEP may differ 
from other pathophysiology conditions re-
sulting in splanchnic ischemia and may, 
therefore, show different reactions on the 
infusion of H2S-donors. Finally, we were 
not able to dose H2S, and its plasma concen-
tration was only mathematically deduced.
CONCLUSION
Exogenous H2S-donor produced a tissue-
selective dilatation of the microcirculation 
capable of increasing blood fl ow in mesen-
teric mucosa both in normal and ischemic 
conditions, without affecting systemic he-
modynamic parameters. Thus, we think 
that H2S could be a potentially useful com-
pound available in critical conditions to 
reverse mesenteric hypoxia-reperfusion 
injury. Studies are needed to assess its ef-
fects on cell metabolism, its precise phar-
macodynamics and pharmacokinetics, and 
to assess the safety of possible future clini-
cal use.
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